belantamab mafodotin,nirogacestat
springworks therapeutics,gsk
['dreamm-5', 'belantamab mafodotin', 'nirogacestat']
#asco22 | june 4 | poster discussion session | hematologic malignancies
"synergistic effects of low-dose belantamab mafodotin in combination w/ gamma-secretase inhibitor (nirogacestat) in patients w/rrmm: dreamm-5 study"
panel speaker: sagar lonial, md 
As Georgia's NCI Comprehensive Cancer Center, we are at the forefront of cancer research, innovation, and discovery. Request patient appointment: (888) 946-7447